GlassScriptPhysician profile
Erin Unger
NPI 1811461346
$2,844.64
in general payments reported to CMS, 2019-2025
32 companies · $481 in 2025
The $481 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,009 · 2022: $470 · 2023: $394 · 2024: $490 · 2025: $481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,366.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $290.17 | 2021-2024 | Orthovisc, Monovisc |
| Ucb, INC. | $261.35 | 2021-2025 | Cimzia, Bimzelx |
| Ferring Pharmaceuticals INC. | $255.57 | 2021-2025 | Euflexxa |
| Amgen INC. | $255.23 | 2021-2023 | Prolia, Evenity |
| Janssen Biotech, INC. | $158.23 | 2024-2025 | Tremfya |
| Vertos Medical, INC. | $155.83 | 2021-2024 | Mild Device Kit |
| Horizon Therapeutics Plc | $152.47 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $137.68 | 2021-2025 | Exparel |
| Zimmer Biomet Holdings, INC. | $125.04 | 2022 | |
| Pacira Therapeutics, INC. | $116.17 | 2021 | |
| Radius Health, INC. | $105.46 | 2021-2025 | Tymlos |
| Alvogen INC | $93.98 | 2023-2025 | Teriparatide |
| Alexion Pharmaceuticals, INC. | $83.80 | 2021-2023 | Strensiq |
| Kowa Pharmaceuticals America, INC. | $83.58 | 2022-2023 | Seglentis |
| Sanofi-Aventis U.S. LLC | $76.70 | 2021-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $73.45 | 2024 | Mako |
| Abbvie INC. | $60.37 | 2021-2023 | |
| Fidia Pharma USA INC. | $55.06 | 2021-2022 | |
| Ani Pharmaceuticals, INC. | $50.13 | 2023-2024 | Purified Cortrophin Gel |
| Boston Scientific Corporation | $35.64 | 2021 | |
| Nalu Medical, INC. | $33.00 | 2024 | Nalu Neurostimulation System |
| Orthofix Medical, INC. | $21.53 | 2024 | Physio-Stim |
| Seapearl East, INC | $21.06 | 2025 | |
| Medtronic, INC. | $20.70 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.91 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $17.71 | 2025 | |
| Cumberland Pharmaceuticals, INC. | $17.31 | 2024 | Caldolor |
| Sobi, INC | $16.54 | 2025 | |
| Invivyd INC | $15.88 | 2025 | Pemgarda |
| Smith+Nephew, INC. | $12.35 | 2021 | |
| Bioventus LLC | $12.34 | 2022 | |
| Royal Biologics, INC. | $10.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Unger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.